Prestige Wealth Management Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $332K | Buy |
1,505
+446
| +42% | +$123K | 0.06% | 134 |
|
|
2026
Q1 | $313K | Sell |
1,059
-37
| -3% | -$11K | 0.06% | 137 |
|
|
2025
Q4 | $299K | Sell |
1,096
-8
| -0.7% | -$2.17K | 0.06% | 140 |
|
|
2025
Q3 | $298K | Buy |
1,104
+9
| +0.8% | +$2.45K | 0.06% | 148 |
|
|
2025
Q2 | $302K | Sell |
1,095
-154
| -12% | -$41.9K | 0.06% | 148 |
|
|
2025
Q1 | $331K | Buy |
1,249
+19
| +2% | +$4.69K | 0.07% | 128 |
|
|
2024
Q4 | $293K | Buy |
1,230
+77
| +7% | +$17.7K | 0.06% | 140 |
|
|
2024
Q3 | $254K | Sell |
1,153
-900
| -44% | -$186K | 0.05% | 143 |
|
|
2024
Q2 | $404K | Buy |
2,053
+960
| +88% | +$198K | 0.09% | 101 |
|
|
2024
Q1 | $235K | Sell |
1,093
-1,103
| -50% | -$232K | 0.05% | 146 |
|
|
2023
Q4 | $474K | Buy |
2,196
+286
| +15% | +$61K | 0.11% | 86 |
|
|
2023
Q3 | $382K | Buy |
1,910
+951
| +99% | +$189K | 0.09% | 96 |
|
|
2023
Q2 | $178K | Sell |
959
-108
| -10% | -$20K | 0.04% | 157 |
|
|
2023
Q1 | $204K | Buy |
1,067
+116
| +12% | +$21K | 0.05% | 148 |
|
|
2022
Q4 | $164K | Sell |
951
-60
| -6% | -$10.4K | 0.04% | 147 |
|
|
2022
Q3 | $180K | Buy |
1,011
+114
| +13% | +$22.5K | 0.05% | 144 |
|
|
2022
Q2 | $184K | Buy |
897
+218
| +32% | +$46.2K | 0.05% | 137 |
|
|
2022
Q1 | $161K | Buy |
679
+62
| +10% | +$14.6K | 0.04% | 155 |
|
|
2021
Q4 | $141K | Buy |
617
+75
| +14% | +$16.5K | 0.03% | 170 |
|
|
2021
Q3 | $105K | Buy |
542
+95
| +21% | +$19.2K | 0.03% | 186 |
|
|
2021
Q2 | $95K | Buy |
447
+315
| +239% | +$66.5K | 0.03% | 188 |
|
|
2021
Q1 | $27K | Buy |
132
+1
| +0.8% | +$197 | 0.01% | 314 |
|
|
2020
Q4 | $24K | Sell |
131
-34
| -21% | -$5.78K | 0.01% | 327 |
|
|
2020
Q3 | $28K | Buy |
165
+14
| +9% | +$2.36K | 0.01% | 311 |
|
|
2020
Q2 | $25K | Sell |
151
-17
| -10% | -$3.05K | 0.01% | 297 |
|
|
2020
Q1 | $29K | Buy |
+168
| New | +$33.4K | 0.01% | 231 |
|
|
2019
Q4 | – | Sell |
-30
| Closed | -$6K | – | 586 |
|
|
2019
Q3 | $6K | Hold |
30
| – | – | ﹤0.01% | 383 |
|
|
2019
Q2 | $6K | Hold |
30
| – | – | ﹤0.01% | 372 |
|
|
2019
Q1 | $5K | Sell |
30
-112
| -79% | -$19.8K | ﹤0.01% | 400 |
|
|
2018
Q4 | $27K | Buy |
+142
| New | +$26.2K | 0.02% | 263 |
|
Other funds holding CME
Prestige Wealth Management Group's CME Position: Q2 2026 in Review
Prestige Wealth Management Group increased its CME Group (CME) stake by 42% in Q2 2026, buying an estimated $123K and bringing the position to 1,505 shares worth $332K. The position accounts for 0.06% of the portfolio, ranked #134.
Prestige Wealth Management Group first reported a position in CME in Q4 2018 and has held it in 30 quarters since. The position peaked at $474K in Q4 2023. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Prestige Wealth Management Group held 1,505 shares of CME Group worth $332K as of Q2 2026.
- Prestige Wealth Management Group bought 446 CME Group shares in Q2 2026, an estimated $123K.
- CME Group made up 0.06% of Prestige Wealth Management Group's portfolio in Q2 2026, its #134 holding.
- Prestige Wealth Management Group first reported a position in CME Group in Q4 2018 and has held it in 30 quarters since.
- Prestige Wealth Management Group's CME Group position peaked at $474K in Q4 2023.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.